PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
21-Oct-2025 Exeliom Biosciences secures €2.85M extension to Series A funding, bringing total round to nearly €12M Andrew Lloyd Associates
21-Oct-2025 Adaptyx Raises $14M in Seed Financing to Launch Wearable Platform for Continuous Multi-Analyte Molecular Monitoring Adaptyx
21-Oct-2025 Global Fund welcomes renewed commitment from GSK and ViiV Healthcare to expand community-led health solutions with £6 million joint pledge ahead of 8th Replenishment Global Fund
21-Oct-2025 Syncona Limited (“Syncona” or the “Company”) Strategy update Syncona
21-Oct-2025 Kelso Pharma prepares for further European growth as Velit Biopharma rebrands as Kelso Pharma Italy Kelso Pharma
21-Oct-2025 Astraveus further strengthens world class leadership team to advance development of Lakhesys Benchtop Cell Factory™ Astraveus
21-Oct-2025 Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose Sanofi
21-Oct-2025 ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors Sanofi
21-Oct-2025 Lundbeck and Contera Pharma announce research collaboration to advance RNA-targeting medicines for serious neurological conditions Lundbeck, Contera Pharma
21-Oct-2025 ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025 ProQR
21-Oct-2025 Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation Galapagos
21-Oct-2025 selectION Demonstrates Safety and Disease-Modifying Mechanism of Action of its Investigational Drug, si-544, in Phase 1b Proof-of-Concept Trial in Psoriasis, a T Cell-Mediated Autoimmune Disease selectION, Inc.
20-Oct-2025 Brainomix e-Lung Enables Earlier Detection of Progressive Pulmonary Fibrosis, New Study Shows Brainomix
20-Oct-2025 SOM Biotech secures clear registrational path for SOM3355 in Huntington’s disease after FDA End‑of‑Phase 2 Meeting Andrew Lloyd Associates
20-Oct-2025 ImmunOs Therapeutics Reports Promising Clinical Activity of IOS-1002 in Advanced Solid Tumors ImmunOs Therapeutics
17-Oct-2025 STEMart Launches Advanced Bacterial Reverse Mutation Test (Ames) Service to Accelerate Medical Device Safety Assessment STEMart
17-Oct-2025 CD Bioparticles Launches Advanced Tumor Organoid & CAF Co-culture Service to Accelerate Cancer Research CD Bioparticles
17-Oct-2025 CD Bioparticles Introduces Custom Enzyme-Conjugated Particles Services for Advancement in Drug Delivery CD Bioparticles
17-Oct-2025 Creative Diagnostics Introduces OGN™ Tumor-derived Organoid Culture Kits to Advance Cancer Research Creative Diagnostics
16-Oct-2025 Syngene International invests in dedicated peptide laboratory and advanced automation Syngene